hydrogen carbonate has been researched along with Hyperuricemia in 9 studies
Bicarbonates: Inorganic salts that contain the -HCO3 radical. They are an important factor in determining the pH of the blood and the concentration of bicarbonate ions is regulated by the kidney. Levels in the blood are an index of the alkali reserve or buffering capacity.
hydrogencarbonate : The carbon oxoanion resulting from the removal of a proton from carbonic acid.
Hyperuricemia: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We assume that decreasing uric acid levels with allopurinol treatment seems to be helpful in restoring endothelial functions, preventing metabolic acidosis and slowing down the progression of CKD." | 9.20 | The effects of allopurinol on metabolic acidosis and endothelial functions in chronic kidney disease patients. ( Altuntaş, A; Bayram, D; İnal, S; Kıdır, V; Orhan, H; Tuğrul Sezer, M, 2015) |
| "We assume that decreasing uric acid levels with allopurinol treatment seems to be helpful in restoring endothelial functions, preventing metabolic acidosis and slowing down the progression of CKD." | 5.20 | The effects of allopurinol on metabolic acidosis and endothelial functions in chronic kidney disease patients. ( Altuntaş, A; Bayram, D; İnal, S; Kıdır, V; Orhan, H; Tuğrul Sezer, M, 2015) |
| "But he developed acute kidney failure (AKF) and hemodialysis was performed." | 1.48 | Rhabdomyolysis following status epilepticus with hyperuricemia: A case report and literature review. ( Hong, S; Huang, H; Wang, L; Yang, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Meremo, A | 1 |
| Paget, G | 1 |
| Duarte, R | 1 |
| Dickens, C | 1 |
| Dix-Peek, T | 1 |
| Bintabara, D | 1 |
| Naicker, S | 1 |
| Peng, Z | 1 |
| Wang, J | 1 |
| Yuan, Q | 1 |
| Xiao, X | 1 |
| Xu, H | 1 |
| Xie, Y | 1 |
| Wang, W | 1 |
| Huang, L | 1 |
| Zhong, Y | 1 |
| Ao, X | 1 |
| Zhang, L | 1 |
| Zhao, M | 1 |
| Tao, L | 1 |
| Zhou, Q | 1 |
| Wang, L | 1 |
| Hong, S | 1 |
| Huang, H | 1 |
| Yang, M | 1 |
| Wilson, FP | 1 |
| Berns, JS | 1 |
| Bayram, D | 1 |
| Tuğrul Sezer, M | 1 |
| İnal, S | 1 |
| Altuntaş, A | 1 |
| Kıdır, V | 1 |
| Orhan, H | 1 |
| Pena-Polanco, JE | 1 |
| Fried, LF | 1 |
| RIESELBACH, RE | 1 |
| BENTZEL, CJ | 1 |
| COTLOVE, E | 1 |
| FREI, E | 1 |
| FREIREICH, EJ | 1 |
| SPERBER, RJ | 1 |
| FISCH, S | 1 |
| DEGRAFF, AC | 1 |
| FREUDENTHAL, RR | 1 |
| Isnard Bagnis, C | 1 |
| Du Montcel, ST | 1 |
| Fonfrede, M | 1 |
| Jaudon, MC | 1 |
| Thibault, V | 1 |
| Carcelain, G | 1 |
| Valantin, MA | 1 |
| Izzedine, H | 1 |
| Servais, A | 1 |
| Katlama, C | 1 |
| Deray, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Chinese Cohort Study of Chronic Kidney Disease[NCT03041987] | 5,000 participants (Anticipated) | Observational | 2012-01-01 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for hydrogen carbonate and Hyperuricemia
| Article | Year |
|---|---|
Tumor lysis syndrome: new challenges and recent advances.
Topics: Acute Kidney Injury; Allopurinol; Bicarbonates; Buffers; Calcium; Diuretics; Enzyme Inhibitors; Febu | 2014 |
Established and Emerging Strategies in the Treatment of Chronic Kidney Disease.
Topics: Allopurinol; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bicarbonate | 2016 |
1 trial available for hydrogen carbonate and Hyperuricemia
| Article | Year |
|---|---|
The effects of allopurinol on metabolic acidosis and endothelial functions in chronic kidney disease patients.
Topics: Acidosis; Adult; Aged; Allopurinol; Bicarbonates; Creatinine; Endothelium; Female; Gout Suppressants | 2015 |
6 other studies available for hydrogen carbonate and Hyperuricemia
| Article | Year |
|---|---|
Demographic and clinical profile of black patients with chronic kidney disease attending a tertiary hospital in Johannesburg, South Africa.
Topics: Acidosis; Aged; Allopurinol; Anemia; Bicarbonates; Cross-Sectional Studies; Diabetes Mellitus; Doxaz | 2022 |
Clinical features and CKD-related quality of life in patients with CKD G3a and CKD G3b in China: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).
Topics: Adult; Anemia; Bicarbonates; Blood Pressure; China; Cholesterol, HDL; Cost of Illness; Female; Glome | 2017 |
Rhabdomyolysis following status epilepticus with hyperuricemia: A case report and literature review.
Topics: Acute Kidney Injury; Bicarbonates; Humans; Hyperuricemia; Male; Renal Dialysis; Rhabdomyolysis; Risk | 2018 |
URIC ACID EXCRETION AND RENAL FUNCTION IN THE ACUTE HYPERURICEMIA OF LEUKEMIA. PATHOGENESIS AND THERAPY OF URIC ACID NEPHROPATHY.
Topics: Acetazolamide; Bicarbonates; Blood; Carbon Isotopes; Drug Therapy; Fluids and Secretions; Hippurates | 1964 |
CORRECTION OF DIURETIC-INDUCED HYPOKALEMIA AND HYPERURICEMIA.
Topics: Bicarbonates; Blood Chemical Analysis; Chlorthalidone; Diuretics; Drug Therapy; Geriatrics; Hydrochl | 1965 |
Changing electrolyte and acido-basic profile in HIV-infected patients in the HAART era.
Topics: Acid-Base Equilibrium; Adult; Aged; Aged, 80 and over; Antiretroviral Therapy, Highly Active; Bicarb | 2006 |